OKYO Pharma Limited (OKYO)

NASDAQ: OKYO · Real-Time Price · USD

1.700

-0.060 (-3.41%)

At close: Feb 20, 2026, 4:00 PM EST

1.720

+0.020 (1.18%)

After-hours: Feb 20, 2026, 7:34 PM EST

OKYO Pharma Employees

OKYO Pharma had 4 employees as of March 31, 2025. The number of employees increased by 1 or 33.33% compared to the previous year.

Employees

4

Change (1Y)

1

Growth (1Y)

33.33%

Revenue / Employee

n/a

Profits / Employee

-$1,153,335

Market Cap

87.33M

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Mar 31, 2025	4	1	33.33%
Mar 31, 2024	3	-5	-62.50%
Mar 31, 2023	8	1	14.29%
Mar 31, 2022	7	1	16.67%
Mar 31, 2021	6	2	50.00%
Mar 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro

Related Stocks

Company Name	Employees
Champions Oncology	213
Verrica Pharmaceuticals	71
Precision BioSciences	67
Pyxis Oncology	44
Biomea Fusion	42
Cognition Therapeutics	28
iBio, Inc.	20
Dogwood Therapeutics	12

Employee Rankings

OKYO News

7 days ago - OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares - GlobeNewsWire
8 days ago - OKYO Pharma Announces Public Offering of Ordinary Shares - GlobeNewsWire
9 days ago - OKYO Pharma Announces Transition of At-The-Market Equity Offering Facility to Leerink Partners - GlobeNewsWire
10 days ago - OKYO Pharma Strengthens World Class Leadership Team with Appointment of Flavio Mantelli, MD, PhD as Chief Medical Officer - GlobeNewsWire
21 days ago - OKYO Pharma Announces Acceptance of Urcosimod Phase 2 Study Results for Presentation at Prestigious ASCRS Annual Meeting - GlobeNewsWire
23 days ago - OKYO Pharma Announces Successful Type C Meeting with the FDA - GlobeNewsWire
4 weeks ago - FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain - GlobeNewsWire
2 months ago - OKYO Pharma to Ring the Opening Bell at Nasdaq - GlobeNewsWire